Companies / Impact Biomedical Inc.
Impact Biomedical Inc.
NYSE: IBOCIK 1834105HOUSTON, TX
Financials · FY2025
Ownership
107.8M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 0.38% | 405,304 |
| 10%+ / strategic | 0.51% | 545,024 |
| Institutions | 2.92% | 3,153,227 |
| Public float | 96.19% | 103,717,676 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
Dss, Inc.10% owner | 0.51% | 545,024 |
Grady JasonDirector | 0.23% | 250,182 |
Macko Todd DChief Financial Officer | 0.14% | 155,122 |
Institutional holders 25
View all →| Holder | Value | % of shares |
|---|---|---|
| $716.2K | 1.11% | |
| $411.5K | 0.76% | |
| $279.6K | 0.56% | |
| $119.6K | 0.24% | |
| $69.6K | 0.13% | |
| $22.5K | 0.03% | |
| $11.5K | 0.02% | |
| $8.3K | 0.02% | |
| $7.1K | 0.01% | |
| $5.2K | <0.01% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $671.6K | +1.1M +1503.87% | 1,192,925 1.11% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $274.2K | +596K +5052.98% | 607,897 0.56% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Exit | Common Stock | $-69.6K | -138K -100.00% | — | low |
| Q4 2024 as of | Barclays PLC 13F manager | Exit | Common Stock | $-2.2K | -1K -100.00% | — | low |
| Q3 2024 as of | Barclays PLC 13F manager | New | Common Stock | $2.2K | +1K | 1,120 <0.01% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common Stock | $-1.4K | -2K -6.03% | 37,427 0.03% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $382 | +756 +450.00% | 924 <0.01% of shares | low |
| Q3 2024 as of | Danske Bank A/S 13F manager | New | Common Stock | $6 | +3 | 3 <0.01% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| IBO | Common Stock | 45259L205 |